June 16 | 2020 2cureX AB establishes collaboration with Scandion Oncology A/S and Erasmus Medical Centre, Rotterdam, in drug-resistant breast cancer patients Read more
May 29 | 2020 2cureX moves forward with the commercialization of IndiTreat by signing a new distributor agreement in Portugal Read more
May 29 | 2020 2cureX moves forward with the commercialization of IndiTreat by signing a new distributor agreement in Portugal Read more
April 29 | 2020 2cureX German subsidiary receives a grant contribution to support the activities towards automation of the IndiTreat® test Read more
April 29 | 2020 2cureX German subsidiary receives a grant contribution to support the activities towards automation of the IndiTreat® test Read more
April 6 | 2020 2cureX i Tyskland får bidrag för att anpassa IndiTreat® för vägledning av immunterapi mot äggstockscancer Read more
April 6 | 2020 2cureX, Germany receives an additional grant for adapting IndiTreat® to guide immunotherapy of ovarian cancer patients Read more